Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIK066 in healthy subjects and patients with T2DM
NCT01407003Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of licogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Jun 2011; status: completed.
02
Drugs
licogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01407003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407003.